Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ross Dennis Zafonte, D.O.

Co-Author

This page shows the publications co-authored by Ross Zafonte and Eric Garshick.
Connection Strength

0.369
  1. Wheelchair use and lipophilic statin medications may influence bone loss in chronic spinal cord injury: findings from the FRASCI-bone loss study. Osteoporos Int. 2016 12; 27(12):3503-3511.
    View in: PubMed
    Score: 0.167
  2. Adiponectin is associated with bone strength and fracture history in paralyzed men with spinal cord injury. Osteoporos Int. 2014 Nov; 25(11):2599-607.
    View in: PubMed
    Score: 0.036
  3. Adiponectin is a candidate biomarker of lower extremity bone density in men with chronic spinal cord injury. J Bone Miner Res. 2014 Jan; 29(1):251-9.
    View in: PubMed
    Score: 0.035
  4. Participation in organized sports is positively associated with employment in adults with spinal cord injury. Am J Phys Med Rehabil. 2013 May; 92(5):393-401.
    View in: PubMed
    Score: 0.034
  5. B-cell maturation antigen, a proliferation-inducing ligand, and B-cell activating factor are candidate mediators of spinal cord injury-induced autoimmunity. J Neurotrauma. 2013 Mar 15; 30(6):434-40.
    View in: PubMed
    Score: 0.033
  6. Sclerostin: a candidate biomarker of SCI-induced osteoporosis. Osteoporos Int. 2013 Mar; 24(3):961-8.
    View in: PubMed
    Score: 0.032
  7. Circulating sclerostin is elevated in short-term and reduced in long-term SCI. Bone. 2012 Sep; 51(3):600-5.
    View in: PubMed
    Score: 0.031
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.